Frost & Sullivan Recognizes Sunquest for its Strides in Precision Medicine and Patient-Centered Healthcare
The company is transforming its long-term strategy to embrace changes in the lab diagnostics space.
SANTA CLARA, California, Sept. 19, 2017 /PRNewswire/ -- Based on recent analysis of the global clinical diagnostic lab IT Market, Frost & Sullivan recognizes Sunquest Information Systems Inc. (Sunquest) with the 2017 Company of the Year Award. Sunquest was founded in 1979 and was acquired by Roper Technologies (formerly Roper Industries Inc.) in 2012. Headquartered in Tucson, Ariz., the company provides software solutions and services that enable complete automation of hospital labs and independent labs, and extends its solution to cater to point-of-care settings, such as surgery and emergency centers, to cover workflows outside of the doctor's office.
Photo - http://mma.prnewswire.com/media/557846/Frost_and_Sullivan_Sunquest_Award.jpg
Sunquest is a strong advocate of the "Five Rights of Laboratory Testing" concept, ensuring that the Right test is performed on the Right patient at the Right time for the Right indicators, leading to the Right diagnosis. With this as its guiding principle, the company has made several strategic product development investments to support the growth of predictive and personalized medicine.
"Sunquest is focused on the evolution of precision medicine. It is investing in leading-edge technology to enable efficient and accurate genetic interpretation and analysis to help clinicians provide highly specific diagnosis and targeted treatment options that take individual variability into account; some of its strategic acquisitions are aligned with the goals of the precision medicine landscape," said Frost & Sullivan Industry Principal, Divyaa Ravishankar.
With a strong international presence, the company processes more than 2 billion lab tests and has a base of more than 500,000 users. Additionally:
- Its reach extends to top hospitals and health systems including Mayo Clinic, UPMC, and Cleveland Clinic.
- Its strong partnerships and ties with the in vitro diagnostic vendor community (such as Roche, Abbott, and Ortho Clinical Diagnostics) is proof of its ability to understand the laboratory analyzer point of view.
- In the United Kingdom, Sunquest now holds more than 70% of NGS Trusts and General Practitioners (GPs) in its wheelhouse.
"During its best practices analysis of the clinical laboratory market, Frost & Sullivan witnessed how Sunquest was transforming its long-term strategy to build solutions that catered to the top trends in the lab diagnostics space, including payer-provider consolidation, the rise of precision medicine, bundled payments, healthcare decentralization, and the transition of care from hospital to ambulatory setting," said Ravishankar.
In addition to its LIMS capabilities, Sunquest has become a leader in diagnostic informatics to address end-to-end diagnostics and drive targeted diagnosis. By thinking of the patient as the center of the ecosystem, Sunquest has taken diagnostic informatics into the future.
"Sunquest is focused on guiding coordinated care through challenges in the clinical lab diagnostic environment with its end-to-end diagnostic capability," said Ravishankar. "Sunquest's health information technology (HIT) offerings targeted at molecular, clinical and anatomic pathology labs address the workflow, connectivity, and interoperability issues that have emerged because of the changing healthcare landscape that requires labs to embrace lean practices." Sunquest also supports outreach programs to offset cuts to reimbursement and declines in collection rates for certain test orders, and maintains the highest standards of regulatory compliance.
"Sunquest is thrilled to be named as the Frost & Sullivan 2017 Company of the Year in recognition of our efforts to improve the laboratory and diagnostic capabilities that impact clinical care for patients around the world," said Matthew Hawkins, CEO of Sunquest Information Systems. "As a global leader in laboratory information systems, Sunquest has deep expertise in creating and implementing world-class lab solutions. Sunquest marquee clients use Sunquest technology to process more than 2 billion laboratory tests annually, serving millions of patients in North America, Europe, the Middle East and Australia."
Each year, Frost & Sullivan presents this award to the company that strives to be best-in-class in three key areas: demand generation, brand development, and competitive positioning.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.
About Sunquest Information Systems
Sunquest Information Systems Inc. provides diagnostic informatics solutions to more than 1,700 laboratories. Since 1979, Sunquest has helped laboratories and healthcare organizations across the world enhance efficiency, improve patient care, and optimize financial results. Sunquest's solutions enable world-class lab capabilities, including multisite, multi-disciplinary support for complex anatomic, molecular and genetic testing, and engagement with physicians and patients outside the hospitals at the point-of-care.
Headquartered in Tucson, AZ with offices in Boston, London, Dubai, United Arab Emirates, and Bangalore, India, Sunquest is a global leader in healthcare information Technology. For more information, visit www.sunquestinfo.com/mitogen
Contact info:
Trish Moxam
Vice President, Corporate Marketing
trish.moxam@sunquestinfo.com
520-237-4024
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion.
Contact:
P: Samantha Park
F: 210.348.1003
E: samantha.park@frost.com
Share this article